Amobarbital

Revision as of 16:02, 27 September 2011 by Matt Pijoan (talk | contribs) (Protected "Amobarbital": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
Jump to navigation Jump to search
Amobarbital
Clinical data
Pregnancy
category
  • ?
Routes of
administration
Oral, IM, IV, Rectal
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability?
MetabolismHepatic
Elimination half-life8-42 hours
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC11H18N2O3
Molar mass226.272

WikiDoc Resources for Amobarbital

Articles

Most recent articles on Amobarbital

Most cited articles on Amobarbital

Review articles on Amobarbital

Articles on Amobarbital in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Amobarbital

Images of Amobarbital

Photos of Amobarbital

Podcasts & MP3s on Amobarbital

Videos on Amobarbital

Evidence Based Medicine

Cochrane Collaboration on Amobarbital

Bandolier on Amobarbital

TRIP on Amobarbital

Clinical Trials

Ongoing Trials on Amobarbital at Clinical Trials.gov

Trial results on Amobarbital

Clinical Trials on Amobarbital at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Amobarbital

NICE Guidance on Amobarbital

NHS PRODIGY Guidance

FDA on Amobarbital

CDC on Amobarbital

Books

Books on Amobarbital

News

Amobarbital in the news

Be alerted to news on Amobarbital

News trends on Amobarbital

Commentary

Blogs on Amobarbital

Definitions

Definitions of Amobarbital

Patient Resources / Community

Patient resources on Amobarbital

Discussion groups on Amobarbital

Patient Handouts on Amobarbital

Directions to Hospitals Treating Amobarbital

Risk calculators and risk factors for Amobarbital

Healthcare Provider Resources

Symptoms of Amobarbital

Causes & Risk Factors for Amobarbital

Diagnostic studies for Amobarbital

Treatment of Amobarbital

Continuing Medical Education (CME)

CME Programs on Amobarbital

International

Amobarbital en Espanol

Amobarbital en Francais

Business

Amobarbital in the Marketplace

Patents on Amobarbital

Experimental / Informatics

List of terms related to Amobarbital

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Amobarbital (formerly known as amylobarbitone) is a drug that is a barbiturate derivative. It has sedative-hypnotic and analgesic properties. It is a white crystalline powder with no odor and a slightly bitter taste. If amobarbital is taken for extended periods of time, physical and psychological dependence can develop.

Pharmacology

According to an in vitro study conducted at the University of British Columbia, amobarbital works by activating GABAA receptors, which decreases input resistance, depresses burst and tonic firing, especially in ventrobasal and intralaminar neurons, while at the same time increasing burst duration and mean conductance at individual chloride channels; this increases both the amplitude and decay time of postsynaptic currents.[1]

It has an LD50 in mice of 212 mg/kg s.c.

Metabolism

Amobarbital undergoes both hydroxylation to form 3'-hydroxyamobarbital,[2] which has both levorotatory and dextrorotatory isomers[3] and N-glucosidation[4] to form 1-(beta-D-glucopyranosyl)amobarbital.[5]

Indications

Approved

Unapproved/Off-Label

  • Sodium amobarbital has a reputation for having activity as a truth serum, where the person under the influence of the drug will submit to almost any request given by another person. It has been used to convict murderers such as Andres English-Howard, who strangled his girlfriend to death but claimed innocence. He was surreptitiously administered the drug, by his attorney, and under the influence of it he revealed why he strangled her and under which circumstances. A year later he confessed, on the stand, and was convicted on the basis of these statements; he later committed suicide in his cell.[6] The use of amobarbital as a truth serum has lost credibility due to the discovery that the subject can be coerced into having a 'false memory' of the event. In controlled doses, it is used in the Narco Analysis test to trace crime and criminals in modern forensics.
  • It was also used in the Battle of the Bulge as a healing pill to send people back to the front.[8]

Contraindications

The following drugs should be avoided when taking amobarbital:

Amobarbital has been known to decrease the effects of hormonal birth control, sometimes to the point of uselessness. Being chemically related to phenobarbital, it might also do the same thing to digitoxin, a cardiac glycoside.

In 1988, Miller et al reported that amobarbital increases benzodiazepine receptor binding in vivo with less potency than secobarbital and pentobarbital (in descending order), but greater than phenobarbital and barbital (in ascending order).[9]

Overdose

Some side effects of overdose include confusion (severe); decrease in or loss of reflexes; drowsiness (severe); fever; irritability (continuing); low body temperature; poor judgment; shortness of breath or slow or troubled breathing; slow heartbeat; slurred speech; staggering; trouble in sleeping; unusual movements of the eyes; weakness (severe). Death can be a result.

See also

References and End Notes

  1. Kim HS, Wan X, Mathers DA, Puil E. "Selective GABA-receptor actions of amobarbital on thalamic neurons." British Journal of Pharmacology. 2004 Oct;143(4):485-94. Epub 2004 Sep 20. PMID 15381635
  2. Maynert EW. "The alcoholic metabolites of pentobarbital and amobarbital in man." Journal of Pharmacology and Experimental Therapeutics. 1965 Oct;150(1):118-21. PMID 5855308
  3. Chemicals: 3'-hydroxyamobarbital The Comparative Toxicology Database.
  4. Tang BK, Kalow W, Grey AA. "Amobarbital metabolism in man: N-glucoside formation." Research Communications in Chemical Pathology and Pharmacology. 1978 Jul;21(1):45-53. PMID 684279
  5. Soine PJ, Soine WH. "High-performance liquid chromatographic determination of the diastereomers of 1-(beta-D-glucopyranosyl)amobarbital in urine." Journal of Chromatography. 1987 Nov 27;422:309-14. PMID 3437019
  6. Truth Serum: A Possible Weapon, 60 Minutes, April 23, 2003.
  7. McCall WV. "The addition of intravenous caffeine during an amobarbital interview." Journal of Psychiatry & Neuroscience. 1992 Nov;17(5):195-7. PMID 1489761
  8. Use of sodium amytal during WWII
  9. Miller LG, Deutsch SI, Greenblatt DJ, Paul SM, Shader RI (1988). "Acute barbiturate administration increases benzodiazepine receptor binding in vivo". Psychopharmacology (Berl). 96 (3): 385–90. PMID 2906155
  1. Controlled Substances in Schedule II Office of Diversion Control, Drug Enforcement Administration.
  2. Controlled Substances in Schedule III Office of Diversion Control, Drug Enforcement Administration.

External links

Template:Barbiturates

Template:SIB de:Amobarbital gl:Amobarbital sl:Amobarbiton fi:Amobarbitaali sv:Amobarbital

Template:WikiDoc Sources